{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T10:09:45Z","timestamp":1784887785130,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1038\/s41401-022-00987-3","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T07:02:44Z","timestamp":1663657364000},"page":"538-545","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Upregulation of dynorphin\/kappa opioid receptor system in the dorsal hippocampus contributes to morphine withdrawal-induced place aversion"],"prefix":"10.1038","volume":"44","author":[{"given":"Yan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-ying","family":"Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song-yu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-zhi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-lian","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-xi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-gen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,20]]},"reference":[{"key":"987_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1126\/science.278.5335.45","volume":"278","author":"AI Leshner","year":"1997","unstructured":"Leshner AI. Addiction is a brain disease, and it matters. Science. 1997;278:45\u20137.","journal-title":"Science"},{"key":"987_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0893-133X(00)00195-0","volume":"24","author":"GF Koob","year":"2001","unstructured":"Koob GF, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology. 2001;24:97\u2013129.","journal-title":"Neuropsychopharmacology"},{"key":"987_CR3","first-page":"73","volume":"137","author":"AR Childress","year":"1993","unstructured":"Childress AR, Hole AV, Ehrman RN, Robbins SJ, McLellan AT, O\u2019Brien CP. Cue reactivity and cue reactivity interventions in drug dependence. NIDA Res Monogr. 1993;137:73\u201395.","journal-title":"NIDA Res Monogr"},{"key":"987_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0091-3057(97)00047-6","volume":"59","author":"A Bechara","year":"1998","unstructured":"Bechara A, Nader K, van der Kooy D. A two-separate-motivational-systems hypothesis of opioid addiction. Pharmacol Biochem Behav. 1998;59:1\u201317.","journal-title":"Pharmacol Biochem Behav"},{"key":"987_CR5","doi-asserted-by":"publisher","first-page":"12244","DOI":"10.1523\/JNEUROSCI.1970-09.2009","volume":"29","author":"YY Hou","year":"2009","unstructured":"Hou YY, Lu B, Li M, Liu Y, Chen J, Chi ZQ, et al. Involvement of actin rearrangements within the amygdala and the dorsal hippocampus in aversive memories of drug withdrawal in acute morphine-dependent rats. J Neurosci. 2009;29:12244\u201354.","journal-title":"J Neurosci"},{"key":"987_CR6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/BF00711306","volume":"7","author":"R Quirion","year":"1987","unstructured":"Quirion R, Pilapil C, Magnan J. Localization of kappa opioid receptor binding sites in human forebrain using [3H] U69, 593: comparison with [3H] bremazocine. Cell Mol Neurobiol. 1987;7:303\u20137.","journal-title":"Cell Mol Neurobiol"},{"key":"987_CR7","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/0166-2236(88)90093-8","volume":"11","author":"A Mansour","year":"1988","unstructured":"Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ. Anatomy of CNS opioid receptors. Trends Neurosci. 1988;11:308\u201314.","journal-title":"Trends Neurosci"},{"key":"987_CR8","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1124\/jpet.111.183905","volume":"339","author":"YJ Wang","year":"2011","unstructured":"Wang YJ, Rasakham K, Huang P, Chudnovskaya D, Cowan A, Liu-Chen LY. Sex difference in \u03ba-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5\u2032-O-(3-[35S] thiotriphosphate) binding in the guinea pig. J Pharmacol Exp Ther. 2011;339:438\u201350.","journal-title":"J Pharmacol Exp Ther"},{"key":"987_CR9","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.lfs.2003.10.041","volume":"75","author":"LY Liu-Chen","year":"2004","unstructured":"Liu-Chen LY. Agonist-induced regulation and trafficking of \u03ba opioid receptors. Life Sci. 2004;75:511\u201336.","journal-title":"Life Sci"},{"key":"987_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.brainres.2009.09.074","volume":"1314","author":"AT Knoll","year":"2010","unstructured":"Knoll AT, Carlezon WA Jr. Dynorphin, stress, and depression. Brain Res. 2010;1314:56\u201373.","journal-title":"Brain Res"},{"key":"987_CR11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.pharmthera.2009.05.006","volume":"123","author":"C Schwarzer","year":"2009","unstructured":"Schwarzer C. 30 years of dynorphins\u2014new insights on their functions in neuropsychiatric diseases. Pharmacol Ther. 2009;123:353\u201370.","journal-title":"Pharmacol Ther"},{"key":"987_CR12","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s00018-011-0844-x","volume":"69","author":"HA Tejeda","year":"2012","unstructured":"Tejeda HA, Shippenberg TS, Henriksson R. The dynorphin\/kappa-opioid receptor system and its role in psychiatric disorders. Cell Mol Life Sci. 2012;69:857\u201396.","journal-title":"Cell Mol Life Sci"},{"key":"987_CR13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00213-013-3195-5","volume":"229","author":"A Van\u2019t Veer","year":"2013","unstructured":"Van\u2019t Veer A, Carlezon WA Jr. Role of kappa-opioid receptors in stress and anxiety-related behavior. Psychopharmacology. 2013;229:435\u201352.","journal-title":"Psychopharmacology"},{"key":"987_CR14","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/aps.2015.32","volume":"36","author":"A Hang","year":"2015","unstructured":"Hang A, Wang YJ, He L, Liu JG. The role of the dynorphin\/\u03ba opioid receptor system in anxiety. Acta Pharmacol Sin. 2015;36:783\u201390.","journal-title":"Acta Pharmacol Sin"},{"key":"987_CR15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1523\/JNEUROSCI.4458-07.2008","volume":"28","author":"BB Land","year":"2008","unstructured":"Land BB, Bruchas MR, Lemos JC, Xu M, Melief EJ, Chavkin C. The dysphoric component of stress is encoded by activation of the dynorphin \u03ba-opioid system. J Neurosci. 2008;28:407\u201314.","journal-title":"J Neurosci"},{"key":"987_CR16","doi-asserted-by":"publisher","first-page":"19168","DOI":"10.1073\/pnas.0910705106","volume":"106","author":"BB Land","year":"2009","unstructured":"Land BB, Bruchas MR, Schattauer S, Giardino WJ, Aita M, Messinger D, et al. Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking. Proc Natl Acad Sci USA. 2009;106:19168\u201373.","journal-title":"Proc Natl Acad Sci USA"},{"key":"987_CR17","doi-asserted-by":"publisher","first-page":"12917","DOI":"10.1523\/JNEUROSCI.2444-15.2015","volume":"35","author":"JM Ehrich","year":"2015","unstructured":"Ehrich JM, Messinger DI, Knakal CR, Kuhar JR, Schattauer SS, Bruchas MR, et al. Kappa opioid receptor-induced aversion requires p38 MAPK activation in VTA dopamine neurons. J Neurosci. 2015;35:12917\u201331.","journal-title":"J Neurosci"},{"key":"987_CR18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.neuroscience.2016.01.052","volume":"320","author":"GY Zan","year":"2016","unstructured":"Zan GY, Wang Q, Wang YJ, Chen JC, Wu X, Yang CH, et al. p38 mitogen-activated protein kinase activation in amygdala mediates \u03ba opioid receptor agonist U50, 488H-induced conditioned place aversion. Neuroscience. 2016;320:122\u20138.","journal-title":"Neuroscience"},{"key":"987_CR19","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00213-003-1680-y","volume":"172","author":"MS Todtenkopf","year":"2004","unstructured":"Todtenkopf MS, Marcus JF, Portoghese PS, Carlezon WA Jr. Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats. Psychopharmacology. 2004;172:463\u201370.","journal-title":"Psychopharmacology"},{"key":"987_CR20","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1016\/j.peptides.2006.08.011","volume":"27","author":"J Liang","year":"2006","unstructured":"Liang J, Li Y, Ping X, Yu P, Zuo Y, Wu L, et al. The possible involvement of endogenous ligands for mu-, delta- and kappa-opioid receptors in modulating morphine-induced CPP expression in rats. Peptides. 2006;27:3307\u201314.","journal-title":"Peptides"},{"key":"987_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.alcohol.2013.05.001","volume":"47","author":"K Gillett","year":"2013","unstructured":"Gillett K, Harshberger E, Valdez GR. Protracted withdrawal from ethanol and enhanced responsiveness stress: regulation via the dynorphin\/kappa opioid receptor system. Alcohol. 2013;47:359\u201365.","journal-title":"Alcohol"},{"key":"987_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.neuropharm.2011.06.014","volume":"62","author":"E Chartoff","year":"2012","unstructured":"Chartoff E, Sawyer A, Rachlin A, Potter D, Pliakas A, Carlezon WA. Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats. Neuropharmacology. 2012;62:167\u201376.","journal-title":"Neuropharmacology"},{"key":"987_CR23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fpsyt.2014.00170","volume":"5","author":"L Lalanne","year":"2014","unstructured":"Lalanne L, Ayranci G, Kieffer BL, Lutz PE. The kappa opioid receptor: from addiction to depression, and back. Front Psychiatry. 2014;5:170.","journal-title":"Front Psychiatry"},{"key":"987_CR24","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/adb.12392","volume":"22","author":"L Lalanne","year":"2017","unstructured":"Lalanne L, Ayranci G, Filliol D, Gav\u00e9riaux\u2010Ruff C, Befort K, Kieffer B, et al. Kappa opioid receptor antagonism and chronic antidepressant treatment have beneficial activities on social interactions and grooming deficits during heroin abstinence. Addict Biol. 2017;22:1010\u201321.","journal-title":"Addict Biol"},{"key":"987_CR25","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1038\/npp.2014.126","volume":"39","author":"P-E Lutz","year":"2014","unstructured":"Lutz P-E, Ayranci G, Chu-Sin-Chung P, Matifas A, Koebel P, Filliol D, et al. Distinct mu, delta, and kappa opioid receptor mechanisms underlie low sociability and depressive-like behaviors during heroin abstinence. Neuropsychopharmacology. 2014;39:2694\u2013705.","journal-title":"Neuropsychopharmacology"},{"key":"987_CR26","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.bbr.2015.05.053","volume":"291","author":"GY Zan","year":"2015","unstructured":"Zan GY, Wang Q, Wang YJ, Liu Y, Hang A, Shu XH, et al. Antagonism of kappa opioid receptor in the nucleus accumbens prevents the depressive-like behaviors following prolonged morphine abstinence. Behav Brain Res. 2015;291:334\u201341.","journal-title":"Behav Brain Res"},{"key":"987_CR27","doi-asserted-by":"publisher","first-page":"109913","DOI":"10.1016\/j.celrep.2021.109913","volume":"37","author":"GY Zan","year":"2021","unstructured":"Zan GY, Wang YJ, Li XP, Fang JF, Yao SY, Du JY, et al. Amygdalar \u03ba-opioid receptor-dependent upregulating glutamate transporter 1 mediates depressive-like behaviors of opioid abstinence. Cell Rep. 2021;37:109913.","journal-title":"Cell Rep"},{"key":"987_CR28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00213-003-1514-y","volume":"170","author":"MR Azar","year":"2003","unstructured":"Azar MR, Jones BC, Schulteis G. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal. Psychopharmacology. 2003;170:42\u201350.","journal-title":"Psychopharmacology"},{"key":"987_CR29","doi-asserted-by":"publisher","first-page":"12005","DOI":"10.1523\/JNEUROSCI.0871-12.2012","volume":"32","author":"Y Liu","year":"2012","unstructured":"Liu Y, Zhou QX, Hou YY, Lu B, Yu C, Chen J, et al. Actin polymerization-dependent increase in synaptic Arc\/Arg3. 1 expression in the amygdala is crucial for the expression of aversive memory associated with drug withdrawal. J Neurosci. 2012;32:12005\u201317.","journal-title":"J Neurosci"},{"key":"987_CR30","doi-asserted-by":"publisher","first-page":"6218","DOI":"10.1038\/s41380-021-01111-3","volume":"26","author":"YJ Wang","year":"2021","unstructured":"Wang YJ, Yu C, Wu WW, Ju YY, Liu Y, Xu C, et al. Alteration of twinfilin1 expression underlies opioid withdrawal-induced remodeling of actin cytoskeleton at synapses and formation of aversive memory. Mol Psychiatry. 2021;26:6218\u201336.","journal-title":"Mol Psychiatry"},{"key":"987_CR31","first-page":"61","volume":"43","author":"JA Gray","year":"1996","unstructured":"Gray JA, McNaughton N. The neuropsychology of anxiety: reprise. Nebr Symp Motiv. 1996;43:61\u2013134.","journal-title":"Nebr Symp Motiv"},{"key":"987_CR32","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.neubiorev.2004.03.005","volume":"28","author":"N McNaughton","year":"2004","unstructured":"McNaughton N, Corr PJ. A two-dimensional neuropsychology of defense: fear\/anxiety and defensive distance. Neurosci Biobehav Rev. 2004;28:285\u2013305.","journal-title":"Neurosci Biobehav Rev"},{"key":"987_CR33","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.pnpbp.2018.06.001","volume":"86","author":"AV Williams","year":"2018","unstructured":"Williams AV, Laman-Maharg A, Armstrong CV, Ramos-Maciel S, Minie VA, Trainor BC. Acute inhibition of kappa opioid receptors before stress blocks depression-like behaviors in California mice. Prog Neuro-Psychopharmacol Biol Psychiatry. 2018;86:166\u201374.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"987_CR34","doi-asserted-by":"publisher","first-page":"18081","DOI":"10.1074\/jbc.M513640200","volume":"281","author":"MR Bruchas","year":"2006","unstructured":"Bruchas MR, Macey TA, Lowe JD, Chavkin C. Kappa opioid receptor activation of p38 MAPK is GRK3-and arrestin-dependent in neurons and astrocytes. J Biol Chem. 2006;281:18081\u20139.","journal-title":"J Biol Chem"},{"key":"987_CR35","doi-asserted-by":"publisher","first-page":"11614","DOI":"10.1523\/JNEUROSCI.3769-07.2007","volume":"27","author":"MR Bruchas","year":"2007","unstructured":"Bruchas MR, Land BB, Aita M, Xu M, Barot SK, Li S, et al. Stress-induced p38 mitogen-activated protein kinase activation mediates \u03ba-opioid-dependent dysphoria. J Neurosci. 2007;27:11614\u201323.","journal-title":"J Neurosci"},{"key":"987_CR36","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.neuron.2011.06.011","volume":"71","author":"MR Bruchas","year":"2011","unstructured":"Bruchas MR, Schindler AG, Shankar H, Messinger DI, Miyatake M, Land BB, et al. Selective p38\u03b1 MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction. Neuron. 2011;71:498\u2013511.","journal-title":"Neuron"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-022-00987-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-022-00987-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-022-00987-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T07:06:44Z","timestamp":1677222404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-022-00987-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,20]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["987"],"URL":"https:\/\/doi.org\/10.1038\/s41401-022-00987-3","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,20]]},"assertion":[{"value":"5 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}